Blog Arasys Perfector - Xanya Sofra Weiss

Xanya Sofra-Weiss, Ph.D

Bioimpendance Neuronal Microstimulation (BNM) was engineered to treat sports injury and muscle atrophy, as well as promote lipolysis and muscle hypertrophy. A clinical study with individuals presenting abnormally clumped RBCs was completed in February 2009 with the Ion Magnum. Results indicate that this technology rapidly and efficiently leads to normalized erythrocytes’ separation at the microscopic level. Red Blood Cells’ (RBCs) separation is crucial for the timely transport of hormones, antibodies, oxygen and nutrients to the cells and waste products to the kidneys. Therefore, blood separation is crucial in a number of biological processes including cellular cleansing, nourishment and oxygenation, endocrine and immune functioning.

Ion Magnum’s (IM) dynamic, multi-sine, analogue waveform was originally tested at the cellular level by Dr. Donald Gilbert (1992), a molecular biologist, and was electronically composed by the Co-Inventor of the first Pacemaker (2008) to resonate at the motor nerve the signal of strenuous exercise normally emitted by the brain. Due to its resonance with the biological signal, the Ion Magnum signal spreads throughout the CNS ultimately triggering hormonal secretion such as Growth Hormone (GF), Thyroxine (T4) and Triiodothyronine (T3) for lipolysis and Insulin Growth Factor (IGF-1) for muscle hypertrophy. Power detox is an additional benefit of Ion Magnum’s induced effortless and painless isometric and isotonic muscle contractions. Several devices stimulate the muscles such asTENS Muscle Stimulators. However, TENS devices deplete ATP. Besides, muscle stimulation does not automatically release hormones. Neuronal synapses activated out of sync with the other inputs to the neuron stands out as odd and are eliminated. Neuronal synapses that are activated in sync with other inputs to the neuron are strengthened. The signal of a device must be in sync with the biological choreography in order to spread via the spinal cord and reach the brain. In sync, or resonance, has been touted by a number of approximate hit-or-miss techniques involving magnetic and electrical fields with dubious inconsistent results. But no technology has ever achieved nerve signaling that is biologically comparable to physical exercise. What the Co-Inventor of the first Pacemaker has accomplished, first in London University and then in the EU funded Research Center for Innovations Science, UK, is a full force, high-speed workout without actual movement, side effects or pain, that enhances hormonal secretion. Lipolysis and muscle hypertrophy following IM treatments has been reported by a number single subject design clinical studies.

IM neuronal microstimulation mobilizes the skeletal muscles into rhythmical pleasurable contractions the way the Pacemaker sets the heart rhythm by brief resonant signals. Intracellularly, this process involves neuronal signals traveling down the spinal cord, carrying the message to the brain via synapses strengthened by virtue of being activated in sync by IM’s resonant inputs. IM’s analogue multi- sine waveform signal has a history of 30 years of research in London University, UK. This bio-identical signal initially targets the motor neurons resulting in rhythmical muscle contractions equivalent to performing high resistance physical activity. The process is initiated at the peripheral motor neuron, then the circuit is completed by outgoing CNS neuron emission. This CNS emission causes the ultimate production of Free T3 and GH/IGF-1, which in turn cause lipolysis and muscular hypertrophy. Triggering hormonal secretion, however, is only part of the process. GF is transported via the blood to the liver to be transformed into IGF-1 which causes muscle hypertrophy. T3 and T4 are also released into the blood stream, being transported throughout the body where they control lipolysis and overall metabolism.

The present study involved 19 randomly selected subjects (17 females and 2 males) all of which received six 45 minute IM treatments every other day. All subjects completed a medical questionnaire. None of the subjects reported any medical disorders. None of the subjects was on a special diet or regular exercise regime. No special supplements or medications were offered during the study. The subjects were instructed to drink an average of 6 glasses of water daily. All subjects were given a 16.9 fluid oz bottle of water prior to the treatment and a second bottle of water after the treatment. METHOD: A drop of the subject’s blood was drawn from the fingertip of each subject and placed on a microscope slide. A special lens inside the microscope projected an intimate view of the living blood onto a computer screen by way of a video camera. The camera was hooked up to the microscope enabling the taking of photographs of a each subject’s blood sample before and after treatment. There were at least 5 pictures taken from different aspects of each sample to control for the possibility of contaminating the validity and reliability of the results by selecting a certain aspect of the sample over another. This was a blind study conducted by individuals that had not been given information as to how to interpret blood samples. VARIABLES:1. The presence of round, separated, freely moving erythrocytes.

2. Rouleau, in which the red blood cells are clumped together and stacked like coins. This suggests the presence of free radicals. Rouleau affects proper oxygenation and favors the growth of unhealthy organisms that can survive in a milieu that is less oxygen rich. Fungi, bacteria, and viruses require less oxygen than healthy tissue.

3. Erythrocyte aggregation, a condition one step worse than rouleau. This is often seen in people with degenerative diseases, degeneration of tissue, low oxygen and acidity. This condition can precede a blood clot which can cause a stroke or heart attack.

4. Poikilocytosis, a condition caused by free radicals. Usually, free radical damage signifies that there will also be damage to the nuclei of tissue cells.

5. Fungal forms: a sign of poor assimilation of nutrients and an acidic condition in the body fluids 6. Bacteria.

7. Thrombocyte Aggregation: when the throbocytes (platelets) aggregate can form a clot which can block an artery. RESULTS:

97% of the subjects had an immediate improvement after the first treatment. However the improvement was on the average limited to going from Erythrocyte Aggregation to mostly Rouleau plus some round, separated, freely moving erythrocytes. Before the 6th treatment, 60% of the subjects had 70% rouleau and 30% normal RBCs separation. 40% of the subjects had mostly round, separated, freely moving erythrocytes before the 6th treatment. After the end of the 6th treatment, 85% of the subjects had mostly round, separated, freely moving erythrocytes. 20% of the subjects had about 30% rouleau and 70% RBCs separation after the 6th treatment. 5% of the subjects had rouleau and minimal RBG’s separation after the 6th treatment. 92% of the subjects had reduced fungal forms, poikilocytosis, thrombocyte aggregation and bacteria. 45% out of that

92% of the subjects with fungal forms, poikilocytosis, thrombocyte aggregation and bacteria present in their blood prior to the first treatment showed none of these forms in the after blood sample after the 6th treatment. 100% of the subjects showed a significant improvement in terms of Poikiloacytosis. These highly significant results may reflect the device’s potential in acting as a mega antioxidant by replenishing the missing electrons of free radicals, thus turning them into stable molecules. CONCLUSION: The results of this clinical microscopy study can be summarized as follows:

1. IM treatments result in an overall improvement in terms of normalized erythrocyte separation.

2. On the average, RBCs separation appears to linearly improve with increased number of treatments.

3. IM treatments appear to have a negative correlation with the number of fungal forms, poikilocytosis, thrombocyte aggregation and bacteria present in the blood prior to the IM treatments, demonstrating a significant reduction of all of the above mentioned variables after the 6th treatment.

4. The enhanced erythrocyte separation as well as the reduction of fungal forms, poikilocytosis, thrombocyte aggregation and bacteria persisted during the intervals between treatments. A longitudinal study is necessary to investigate the total length of time during which such normalization effects continue to be present. So far, two subjects that have been followed up over a period of three months have sustained the Ion Mangum’s positive effects on RBCs separation. This technology that was initially based on research associated with the Pacemaker and gained its popularity in the field of body building and cosmetic procedures is now coming full circle by offering benefits that can be potentially used in Medicine to reduce the incidence or progression of cardiac disorders as a result of erythrocyte aggregation. IM treatments effortlessly exercise the body without lactic acid production while enhancing RBCs separation. This process of exercis ing without actually exercising could solve the dilemma caused by intolerance to Statins which is associated with intolerance to exercise, possibly due to lactic acid formation. Statins are widely prescribed to lower high blood cholesterol and thus reduce the risk for heart disease.